American Association of Christian Counselors Prove their Interest in Brain Based Health and Drug Free Solutions
NASHVILLE, TN / ACCESSWIRE / September 25, 2015 / Nexalin Technology announces its booth has been packed at various times at The Opryland Hotel where the company is introducing its brain based health platform as a drug free solution to anxiety, depression and insomnia (ADI) at the American Association of Christian Counselors 2015 “Be Strong” World Conference. Many of the attendees at this important conference are seeing Nexalin for the first time and are excited to investigate a drug free solution. Mark White, Vice President of Operations, will be leading presentations on behalf of the company to show how Nexalin’s drug free alternative is designed to work with prescription drugs or as a stand-alone treatment. (Please consult with your medical professional prior to using Nexalin or reducing prescription doses.) Nexalin is an FDA cleared medical device which has treated thousands of patients without incident and has an extremely high rate of efficacy.
Nexalin Technology believes counselors should consider the most advanced treatments in the field of mental health that not only measure treatment outcomes for success, but also utilize the most advanced technologies available. According to test results, FDA cleared technologies such as Nexalin support treating the brain directly. Nexalin CEO, Randall Letcavage stated, “We believe we have cracked the code and found the right combination of frequency and waveform that allows Nexalin to ‘reset the brain.’ In layman’s terms sometime during your lifetime chemical imbalances may become present in the brain that can be caused by hundreds of factors (pesticides, trauma, drugs and alcohol to name a few). We believe and data supports that Nexalin can reset the brain to the proper chemical balance in certain areas and situations. We are seeing people improve in much shorter periods of time as compared to many other treatment protocols.”
Nexalin’s patented waveform is highly effective in stimulating the mid-brain. More significantly, scientific data suggests the Nexalin waveform effectively resets the hypothalamus of the brain without the introduction of pharmaceutical medication.
The AACC’s greatest asset is having nearly 50,000 members worldwide including Professional Counselors, Marriage and Family Therapists, Social Workers, Psychiatrists, Psychologists, Pastors, Students, Lay Helpers and more. These “people helpers” come together through AACC to learn, lead and influence. AACC is a place for people to feel that they belong, an organization that provides support, education, resources, encouragement along with striving to be practical, biblically-based and clinically excellent.
This conference will allow people to experience a landmark event that honors Christ and represents the best in counseling and spiritual care. There will be people there who share a desire to reach out to those who are hurting and restore help. There is the ability to develop professional relationships with Christian counselors from across the nation and around the world. People can discover practical tips and strategies to more effectively minister to others.
AACC World Conference expects more than 7,000 people. There will be more than 200 Exhibits, 54 pre-con workshops, and 23 Counseling Tracks. There is also Music and Comedy which includes Chonda Pierce, whose Southern Charm and laser sharp wit are a “must see”. Some of the Plenary Speakers consist of Governor Mike Huckabee, Jase Robertson of Duck Commander, John Townsend of Cloud-Townsend Resources, to mention a few.
About Nexalin Technology, Inc.
Nexalin Technology owns an FDA cleared medical device which creates a frequency and waveform that seems to affect key brain structures involved in the regulation of neurochemistry. Data suggests the Nexalin waveform effectively resets the hypothalamus of the brain, without the introduction of pharmaceuticals. Clinical research indicates that normalizing the production of various neurotransmitters, including Dopamine, Serotonin, and Norepinephrine may begin as early as the initial treatment. In recent studies, patients report on average, 80% to 97% of sustained improvement in all symptoms. For more information regarding Nexalin, including providers near you, please visit www.nexalin.com. If you are a medical professional interested in learning more, please call (714)258-8004.
CONTACT:
Nexalin Technology, Inc.
www.nexalin.com
Medical professionals interested in learning more, please call (714)258-8004
SOURCE: Nexalin Technology, Inc.
ReleaseID: 432222